The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Targeting the transforming growth factor-β signaling pathway in human cancer
Open accessAbstract
The transforming growth factor-ss (TGF-beta) signaling pathway plays a pivotal role in diverse cellular processes. TGF-beta switches its role from a tumor suppressor in normal or dysplastic cells to a tumor promoter in advanced cancers. It is widely believed that the Smad-dependent pathway is involved in TGF-beta tumor-suppressive functions, whereas activation of Smad-independent pathways, coupled with the loss of tumor-suppressor functions of TGF-beta, is important for its pro-oncogenic functions. TGF-beta signaling has been considered a useful therapeutic target. The discovery of oncogenic actions of TGF-beta has generated a great deal of enthusiasm for developing TGF-beta signaling inhibitors for the treatment of cancer. The challenge is to identify the group of patients where targeted tumors are not only refractory to TGF-beta-induced tumor suppressor functions but also responsive to the tumor-promoting effects of TGF-beta. TGF-beta pathway inhibitors, including small and large molecules, have now entered clinical trials. Preclinical studies with these inhibitors have shown promise in a variety of different tumor models. Here, we focus on the mechanisms of signaling and specific targets of the TGF-beta pathway that are critical effectors of tumor progression and invasion. This report also examines the therapeutic intervention of TGF-ss signaling in human cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
Shi, Y., & Massagué, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00432-x · Cited by 5,857
Smad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,373
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320530 · Cited by 2,649
Mechanisms of Hepatic Fibrogenesis
Friedman, S. L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.003 · Cited by 2,634
Massagué, J., Seoane, J., & Wotton, D. (2005) · Genes & Development · doi:10.1101/gad.1350705 · Cited by 2,452
Epithelial–mesenchymal transitions in development and pathologies
Thiery, J. P. (2003) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2003.10.006 · Cited by 1,704
Making sense of latent TGFβ activation
Annes, J. P., Munger, J. S., & Rifkin, D. B. (2003) · Journal of Cell Science · doi:10.1242/jcs.00229 · Cited by 1,628
TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia
Bhowmick, N. A., Chytil, A., Plieth, D., Gorska, A. E., Dumont, N., Shappell, S., Washington, M. K., Neilson, E. G., & Moses, H. L. (2004) · Science · doi:10.1126/science.1090922 · Cited by 1,401 · cited 1×
“Recently, TGF-b’s role was highlighted in stromal–epithelial crosstalk regulation of cancer: it was shown that stromal fibroblast-induced TGF-b signaling can be important for the suppression of tumorigenesis in adjacent epithelium [46].”
BackgroundTGFβ: the molecular Jekyll and Hyde of cancer
Bierie, B., & Moses, H. L. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1926 · Cited by 1,267
SMAD proteins control DROSHA-mediated microRNA maturation
Davis, B. N., Hilyard, A. C., Lagna, G., & Hata, A. (2008) · Nature · doi:10.1038/nature07086 · Cited by 1,244
A mechanism of repression of TGFbeta / Smad signaling by oncogenic Ras
Kretzschmar, M., Doody, J., Timokhina, I., & Massague, J. (1999) · Genes & Development · doi:10.1101/gad.13.7.804 · Cited by 1,004
Bhowmick, N. A., Ghiassi, M., Bakin, A., Aakre, M., Lundquist, C. A., Engel, M. E., Arteaga, C. L., & Moses, H. L. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.1.27 · Cited by 1,004
Moustakas, A., & Heldin, C.-H. (2005) · Journal of Cell Science · doi:10.1242/jcs.02554 · Cited by 958
Yang, L., Huang, J., Ren, X., Gorska, A. E., Chytil, A., Aakre, M., Carbone, D. P., Matrisian, L. M., Richmond, A., Lin, P. C., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2007.12.004 · Cited by 918
Padua, D., & Massagué, J. (2009) · Cell Research · doi:10.1038/cr.2008.316 · Cited by 809
Extracellular control of TGFβ signalling in vascular development and disease
ten Dijke, P., & Arthur, H. M. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2262 · Cited by 778
Massagué, J., & Gomis, R. R. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.04.033 · Cited by 721
Role of transforming growth factor-β superfamily signaling pathways in human disease
Gordon, K. J., & Blobe, G. C. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.01.006 · Cited by 641
Valcourt, U., Kowanetz, M., Niimi, H., Heldin, C.-H., & Moustakas, A. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-08-0658 · Cited by 610
Intestinal Tumorigenesis in Compound Mutant Mice of both Dpc4(Smad4) and Apc Genes
Takaku, K., Oshima, M., Miyoshi, H., Matsui, M., Seldin, M. F., & Taketo, M. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81132-0 · Cited by 609
Development of TGF-β signalling inhibitors for cancer therapy
Yingling, J. M., Blanchard, K. L., & Sawyer, J. S. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1580 · Cited by 549
Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway
Kang, Y., He, W., Tulley, S., Gupta, G. P., Serganova, I., Chen, C.-R., Manova-Todorova, K., Blasberg, R., Gerald, W. L., & Massagué, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506517102 · Cited by 532
Actions of TGF-β as tumor suppressor and pro-metastatic factor in human cancer
Pardali, K., & Moustakas, A. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.06.004 · Cited by 526
TGF-? receptor function in the endothelium
LEBRIN, F., DECKERS, M., BERTOLINO, P., & TENDIJKE, P. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.10.036 · Cited by 513
Cell adhesion protein receptors as targets for transforming growth factor-$beta; action
IGNOTZ, R. (1987) · Cell · doi:10.1016/0092-8674(87)90146-2 · Cited by 485
BIERIE, B., & MOSES, H. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.09.006 · Cited by 477
Regulation of cell proliferation by Smad proteins
Ten Dijke, P., Goumans, M., Itoh, F., & Itoh, S. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10066 · Cited by 450
Jinnin, M., Ihn, H., & Tamaki, K. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.017483 · Cited by 445
Myeroff, L. L., Parsons, R. E., Kim, S., Hedrick, L., Cho, K. R., Orth, K., Mathis, J. M., Kinzler, K. W., Lutterbaugh, J., & Park, K. (1995) · PubMed · Cited by 445
Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis
Miyaki, M., Iijima, T., Konishi, M., Sakai, K., Ishii, A., Yasuno, M., Hishima, T., Koike, M., Shitara, N., Iwama, T., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202642 · Cited by 436
Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases
Muraoka, R. S., Dumont, N., Ritter, C. A., Dugger, T. C., Brantley, D. M., Chen, J., Easterly, E., Roebuck, L. R., Ryan, S., Gotwals, P. J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215234 · Cited by 415
Uhl, M., Aulwurm, S., Wischhusen, J., Weiler, M., Ma, J. Y., Almirez, R., Mangadu, R., Liu, Y.-W., Platten, M., Herrlinger, U., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1013 · Cited by 414
Cloning of a Type I TGF-β Receptor and Its Effect on TGF-β Binding to the Type II Receptor
Ebner, R., Chen, R.-H., Shum, L., Lawler, S., Zioncheck, T. F., Lee, A., Lopez, A. R., & Derynck, R. (1993) · Science · doi:10.1126/science.8388127 · Cited by 399
Akt interacts directly with Smad3 to regulate the sensitivity to TGF-β-induced apoptosis
Conery, A. R., Cao, Y., Thompson, E. A., Townsend, C. M., Ko, T. C., & Luo, K. (2004) · Nature Cell Biology · doi:10.1038/ncb1117 · Cited by 398
Differentiation plasticity regulated by TGF-β family proteins in development and disease
Derynck, R., & Akhurst, R. J. (2007) · Nature Cell Biology · doi:10.1038/ncb434 · Cited by 382
Migratory neighbors and distant invaders: tumor-associated niche cells
Wels, J., Kaplan, R. N., Rafii, S., & Lyden, D. (2008) · Genes & Development · doi:10.1101/gad.1636908 · Cited by 381
Metastasis is driven by sequential elevation of H-ras and Smad2 levels
Oft, M., Akhurst, R. J., & Balmain, A. (2002) · Nature Cell Biology · doi:10.1038/ncb807 · Cited by 373
Kowanetz, M., Valcourt, U., Bergström, R., Heldin, C.-H., & Moustakas, A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.10.4241-4254.2004 · Cited by 346
Biswas, S., Guix, M., Rinehart, C., Dugger, T. C., Chytil, A., Moses, H. L., Freeman, M. L., & Arteaga, C. L. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30740 · Cited by 346
Tojo, M., Hamashima, Y., Hanyu, A., Kajimoto, T., Saitoh, M., Miyazono, K., Node, M., & Imamura, T. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00103.x · Cited by 339
Melisi, D., Ishiyama, S., Sclabas, G. M., Fleming, J. B., Xia, Q., Tortora, G., Abbruzzese, J. L., & Chiao, P. J. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0337 · Cited by 323
Chen, C.-R., Kang, Y., & Massagué, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.992 · Cited by 320
Dooley, S., Hamzavi, J., Ciuclan, L., Godoy, P., Ilkavets, I., Ehnert, S., Ueberham, E., Gebhardt, R., Kanzler, S., Geier, A., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.04.038 · Cited by 281
Guasch, G., Schober, M., Pasolli, H. A., Conn, E. B., Polak, L., & Fuchs, E. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.08.020 · Cited by 268
Targeting the TGFβ signaling network in human neoplasia
Dumont, N., & Arteaga, C. L. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00135-1 · Cited by 242
Horowitz, J. C., Lee, D. Y., Waghray, M., Keshamouni, V. G., Thomas, P. E., Zhang, H., Cui, Z., & Thannickal, V. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306248200 · Cited by 239 · cited 1×
“This protection from cell death is blocked by the PI3 kinase inhibitor LY-294002 [100] or TGF-bRI kinase inhibitors [101].”
BackgroundSawyer, J. S., Anderson, B. D., Beight, D. W., Campbell, R. M., Jones, M. L., Herron, D. K., Lampe, J. W., McCowan, J. R., McMillen, W. T., Mort, N., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0205705 · Cited by 236
Nucleocytoplasmic shuttling of Smad proteins
Hill, C. S. (2009) · Cell Research · doi:10.1038/cr.2008.325 · Cited by 234
Differentiation plasticity regulated by TGF-|[beta]| family proteins in development and disease
Derynck, R., & Akhurst, R. J. (2007) · Nature · doi:10.1038/ncb0907-1000 · Cited by 227
Evaluation of Anti-TGF-β2 Antibody as a New Postoperative Anti-scarring Agent in Glaucoma Surgery
Mead, A. L., Wong, T. T. L., Cordeiro, M. F., Anderson, I. K., & Khaw, P. T. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-0978 · Cited by 225
Hau, P., Jachimczak, P., Schlingensiepen, R., Schulmeyer, F., Jauch, T., Steinbrecher, A., Brawanski, A., Proescholdt, M., Schlaier, J., Buchroithner, J., et al. (2007) · Oligonucleotides · doi:10.1089/oli.2006.0053 · Cited by 215
Moon, J.-A., Kim, H.-T., Cho, I.-S., Sheen, Y. Y., & Kim, D.-K. (2006) · Kidney International · doi:10.1038/sj.ki.5001775 · Cited by 197
Stable Overexpression of Smad7 in Human Melanoma Cells Impairs Bone Metastasis
Javelaud, D., Mohammad, K. S., McKenna, C. R., Fournier, P., Luciani, F., Niewolna, M., André, J., Delmas, V., Larue, L., Guise, T. A., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3950 · Cited by 195
Hjelmeland, M. D., Hjelmeland, A. B., Sathornsumetee, S., Reese, E. D., Herbstreith, M. H., Laping, N. J., Friedman, H. S., Bigner, D. D., Wang, X.-F., & Rich, J. N. (2004) · PubMed · Cited by 192
Nemunaitis, J., Jahan, T., Ross, H., Sterman, D., Richards, D., Fox, B., Jablons, D., Aimi, J., Lin, A., & Hege, K. (2006) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700922 · Cited by 180
Ehata, S., Hanyu, A., Fujime, M., Katsuno, Y., Fukunaga, E., Goto, K., Ishikawa, Y., Nomura, K., Yokoo, H., Shimizu, T., et al. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2006.00357.x · Cited by 180
Hjelmeland, M. D., Hjelmeland, A. B., Sathornsumetee, S., Reese, E. D., Herbstreith, M. H., Laping, N. J., Friedman, H. S., Bigner, D. D., Wang, X.-F., & Rich, J. N. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.737.3.6 · Cited by 177
Add-On Anti–TGF-β Antibody to ACE Inhibitor Arrests Progressive Diabetic Nephropathy in the Rat
Benigni, A., Zoja, C., Corna, D., Zatelli, C., Conti, S., Campana, M., Gagliardini, E., Rottoli, D., Zanchi, C., Abbate, M., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000074238.61967.b7 · Cited by 176
STRAP and Smad7 Synergize in the Inhibition of Transforming Growth Factor β Signaling
Datta, P. K., & Moses, H. L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.9.3157-3167.2000 · Cited by 175
Self-citationPhase I–II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas
Galanis, E., Okuno, S. H., Nascimento, A. G., Lewis, B. D., Lee, R. A., Oliveira, A. M., Sloan, J. A., Atherton, P., Edmonson, J. H., Erlichman, C., et al. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302436 · Cited by 170
Dual Role of Transforming Growth Factor β in Mammary Tumorigenesis and Metastatic Progression
Muraoka-Cook, R. S., Dumont, N., & Arteaga, C. L. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.937s.11.2 · Cited by 168
Angiotensin-Converting Enzyme Inhibitors: A New Mechanism of Action
Peng, H., Carretero, O. A., Vuljaj, N., Liao, T.-D., Motivala, A., Peterson, E. L., & Rhaleb, N.-E. (2005) · Circulation · doi:10.1161/circulationaha.104.528695 · Cited by 160
Owens, D. W., McLean, G. W., Wyke, A. W., Paraskeva, C., Parkinson, E. K., Frame, M. C., & Brunton, V. G. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.1.51 · Cited by 158
Karumanchi, S. A., Knebelmann, B., Grüning, W., Dhanabal, M., Walz, G., Stillman, I. E., & Sukhatme, V. P. (1999) · PubMed · Cited by 147
Reiß, M. (1999) · Microbes and Infection · doi:10.1016/s1286-4579(99)00251-8 · Cited by 146
Muraoka-Cook, R. S., Shin, I., Yi, J. Y., Easterly, E., Barcellos‐Hoff, M. H., Yingling, J. M., Zent, R., & Arteaga, C. L. (2005) · Oncogene · doi:10.1038/sj.onc.1208964 · Cited by 139
Battaglia, S., Benzoubir, N., Nobilet, S., Charneau, P., Samuel, D., Zignego, A. L., Atfi, A., Bréchot, C., & Bourgeade, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004355 · Cited by 138
Subramanian, G., Schwarz, R. E., Higgins, L., McEnroe, G., Chakravarty, S., Dugar, S., & Reiss, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0018 · Cited by 138
Identification of STRAP, a Novel WD Domain Protein in Transforming Growth Factor-β Signaling
Datta, P. K., Chytil, A., Gorska, A. E., & Moses, H. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.52.34671 · Cited by 136
Self-citationTargeting transforming growth factor-β signaling in liver metastasis of colon cancer
Zhang, B., Halder, S. K., Zhang, S., & Datta, P. K. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.11.035 · Cited by 134
Self-citationRomero–Gallo, J., Sözmen, E. G., Chytil, A., Russell, W. E., Whitehead, R. H., Parks, W. T., Holdren, M. S., Her, M. F., Gautam, S., Magnuson, M. A., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208475 · Cited by 133
Bierie, B., Stover, D. G., Abel, T. W., Chytil, A., Gorska, A. E., Aakre, M. E., Forrester, E., Yang, H. H., Wagner, K., & Moses, H. L. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5597 · Cited by 128
Biological impediments to monoclonal antibody–based cancer immunotherapy
Christiansen, J., & Rajasekaran, A. K. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1493.3.11 · Cited by 125
A Transforming Growth Factor β-Induced Smad3/Smad4 Complex Directly Activates Protein Kinase A
Zhang, L., Duan, C. J., Binkley, C. E., Li, G., Uhler, M. D., Logsdon, C. D., & Simeone, D. M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.5.2169-2180.2004 · Cited by 124
Smad7 induces tumorigenicity by blocking TGF-β-induced growth inhibition and apoptosis
Halder, S. K., Beauchamp, R. D., & Datta, P. K. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.03.009 · Cited by 116
Self-citationBandyopadhyay, A. M., Zhu, Y., Cibull, M. L., Bao, L., Chen, C., & Sun, L. (1999) · PubMed · Cited by 115
TGF Beta Inhibition for Cancer Therapy
Saunier, E. F., & Akhurst, R. J. (2006) · Current Cancer Drug Targets · doi:10.2174/156800906778742460 · Cited by 114
Suzuki, E., Kim, S., Cheung, H.-K., Corbley, M. J., Zhang, X., Sun, L., Shan, F., Singh, J., Lee, W.-C., Albelda, S. M., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2389 · Cited by 113
Yang, L., Mao, C., Teng, Y., Li, W., Zhang, J., Cheng, X., Li, X., Han, X., Xia, Z., Deng, H., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0800 · Cited by 108
Lu, T., Burdelya, L. G., Swiatkowski, S. M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402048101 · Cited by 104
Transforming growth factor-beta receptor type I gene is frequently mutated in ovarian carcinomas.
Chen, T., Triplett, J., Dehner, B., Hurst, B. M., Colligan, B. M., Pemberton, J. O., Graff, J. R., & Carter, J. H. (2001) · PubMed · Cited by 101
Schlingensiepen, K., Fischer-Blass, B., Schmaus, S., & Ludwig, S. (2007) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-540-71279-4_16 · Cited by 100
Structural alterations of transforming growth factor-? receptor genes in human cervical carcinoma
Chen, T., de Vries, E. G. E., Hollema, H., Yegen, H. A., Vellucci, V. F., Strickler, H. D., Hildesheim, A., & Reiss, M. (1999) · International Journal of Cancer · Cited by 100
Law, B. K., Chytil, A., Dumont, N., Hamilton, E. G., Waltner-Law, M. E., Aakre, M. E., Covington, C. D., & Moses, H. L. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.23.8184-8198.2002 · Cited by 99
JNK Regulates Autocrine Expression of TGF-β1
Ventura, J., Kennedy, N. J., Flavell, R. A., & Davis, R. J. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.06.007 · Cited by 96
Inhibiting TGF-β signaling restores immune surveillance in the SMA-560 glioma model
Tran, T.-T., Uhl, M., Jing, Y., et al. (2007) · Neuro-Oncology · doi:10.1215/15228517-2007-010 · Cited by 96
Rotzer, D., Roth, M., Lutz, M., Lindemann, D., Sebald, W., & Knaus, P. (2001) · The EMBO Journal · doi:10.1093/emboj/20.3.480 · Cited by 94
Rowland‐Goldsmith, M., Maruyama, H., Matsuda, K., Idezawa, T., Ralli, M., Ralli, S., & Korc, M. (2002) · PubMed · Cited by 92
TGF-β inhibitors for the treatment of cancer
Lahn, M. M. F., Kloeker, S., & Berry, B. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.6.629 · Cited by 89
Bandyopadhyay, A. M., Zhu, Y., Malik, S. N., Kreisberg, J. I., Brattain, M. G., Sprague, E. A., Luo, J., López‐Casillas, F., & Sun, L. (2002) · Oncogene · doi:10.1038/sj.onc.1205439 · Cited by 87
Nam, J., Suchar, A. M., Kang, M., Stuelten, C. H., Tang, B., Michalowska, A. M., Fisher, L. W., Fedarko, N. S., Jain, A., Pinkas, J., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0068 · Cited by 86
2 TGF-β and the TGF-β FamilyPreprint
Derynck, R., & Miyazono, K. (2008) · Cold Spring Harbor Monograph Archive · doi:10.1101/087969752.50.29 · Cited by 82
Tanaka, Y., Kobayashi, H., Suzuki, M., Kanayama, N., & Terao, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309131200 · Cited by 77
Aguilera, A. I., Yáñez‐Mó, M., Selgas, R., Sánchez‐Madrid, F., & López‐Cabrera, M. (2005) · PubMed · Cited by 74
Chen, T., Wu, Y., Wells, R. G., Rimm, D. L., McNiff, J. M., Leffell, D. J., & Reiß, M. (2001) · International Journal of Cancer · doi:10.1002/ijc.1381 · Cited by 74
Cheng, N., Chytil, A., Shyr, Y., Joly, A. H., & Moses, H. L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3381 · Cited by 73
Involvement of c-Src kinase in the regulation of TGF-β1-induced apoptosis
Park, S. S., Eom, Y. W., Kim, E. H., Lee, J., Min, D. S., Kim, S., Kim, S., & Choi, K. S. (2004) · Oncogene · doi:10.1038/sj.onc.1207856 · Cited by 67
Lateral signaling enhances TGF-β response complexity
Byfield, S. D. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2004.01.001 · Cited by 64
Loss of Smad4 expression predicts liver metastasis in human colorectal cancer
Losi, L., Bouzourène, H., & Benhattar, J. (2007) · Oncology Reports · doi:10.3892/or.17.5.1095 · Cited by 63
In vivo disruption of TGF-β signaling by Smad7 leads to premalignant ductal lesions in the pancreas
Kuang, C., Xiao, Y., Liu, X., Stringfield, T. M., Zhang, S., Wang, Z., & Chen, Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508977103 · Cited by 63
Cui, Q., Lim, S. K., Zhao, B. M., & Hoffmann, F. M. (2005) · Oncogene · doi:10.1038/sj.onc.1208556 · Cited by 56
Ku, J., Park, S. H., Yoon, K., Shin, Y., Kim, K., Choi, J.-S., Kang, H.-C., Kim, I.-J., Han, I., & Park, J. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.05.008 · Cited by 43
Kim, J.-T., & Joo, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201178200 · Cited by 38
Calvo, E., Baselga, J. M., Glatt, S., Cleverly, A., Lahn, M., Arteaga, C. L., Rothenberg, M. L., & Carducci, M. A. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.14554 · Cited by 38
Novel Oncogenic Protein Kinase Inhibitors for Cancer Therapy
Sawyer, T. K. (2004) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1568011043352830 · Cited by 37
Monoclonal Antibodies in Cancer Therapy
Gatto, B. (2004) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1568011043352713 · Cited by 28
The disposition (ADME) of antisense oligonucleotides.
Dvorchik, B. H. (2000) · PubMed · Cited by 15
Ilaria, R. L., Simon, G. R., Sovak, M. A., Burton, M. K., Cleverly, A., Sykes, A. K., de Alwis, D. P., Wagner, M. M., & Spriggs, D. R. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.2515 · Cited by 8
Transforming Growth Factor-β (TGF-β) Signaling Inhibitors in Cancer Therapy
Datta, P. K., & Mann, J. R. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-293-9_35 · Cited by 3
Self-citationLacher, M. D., Korn, W. M., & Akhurst, R. J. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-293-9_43 · Cited by 3
Cited by
The polarization of immune cells in the tumour environment by TGFβ
Flavell, R. A., Sanjabi, S., Wrzesinski, S. H., & Licona-Limón, P. (2010) · Nature Reviews Immunology · doi:10.1038/nri2808 · Cited by 940
Lahn, M., Herbertz, S., Sawyer, J. S., Stauber, A. J., Gueorguieva, I., Driscoll, K. E., Estrem, S. T., Cleverly, A. L., Desaiah, D., Guba, S. C., et al. (2015) · Drug Design, Development and Therapy · doi:10.2147/dddt.s86621 · Cited by 554
Tissue invasion and metastasis: Molecular, biological and clinical perspectives
Jiang, W. G., Sanders, A. J., Katoh, M., Ungefroren, H., Gieseler, F., Prince, M., Thompson, S. K., Zollo, M., Spano, D., Dhawan, P., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.008 · Cited by 515
Syed, V. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25496 · Cited by 482
Holmgaard, R. B., Schaer, D. A., Li, Y., Castaneda, S. P., Murphy, M. Y., Xu, X., Inigo, I., Dobkin, J., Manro, J. R., Iversen, P. W., et al. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0356-4 · Cited by 356
Metadata
- Authors
- Nagaraj, N. S., & Datta, P. K.
- Venue
- Expert Opinion on Investigational Drugs
- Publisher
- Informa UK Limited
- Published
- 2009-12-10
- Volume
- 19
- Issue
- 1
- Pages
- 77-91
- ISSN
- 1354-3784 (ISSN-L)
- 1744-7658
- OpenAlex
- W2132997519
- Cited by
- 262
- References
- 113
- FWCI
- 4.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.